Compare

MOTS-c vs PT-141

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.
XRedditFacebook

MOTS-c

111 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 17% · Mixed 2% · Unfavorable overall 81%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Appetite
230
Energy
45
Mood
1
Recovery
1

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Injection site irritation
191

Self-reported dose per injection

Median bucket: 2+ mg · Most common: 2+ mg

Reports span 0 to ≥ 2 mg (open-ended top bucket)

0–0.025 mg
4
0.1–0.2 mg
1
0.2–0.4 mg
8
0.4–0.6 mg
11
0.6–1 mg
8
1–2 mg
42
2+ mg
157

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 56% said they felt similar to their last entry, 31% more positive, and 13% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 44 days · Based on 45 repeat reporters

PT-141

27 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 3% · Mixed 2% · Unfavorable overall 95%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Libido
113

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Nausea
38
Headache
37
Injection site irritation
35

Self-reported dose per injection

Median bucket: 2+ mg · Most common: 2+ mg

Reports span 0.1 to ≥ 2 mg (open-ended top bucket)

0.1–0.2 mg
1
0.2–0.4 mg
2
0.4–0.6 mg
9
0.6–1 mg
3
1–2 mg
8
2+ mg
90

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 87% said they felt similar to their last entry, 13% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 100 days · Based on 23 repeat reporters

Explore other peptides